Excision BioTherapeutics

📍 Watertown, United States🗓 Founded 2015👥 36 employees💰 Last funded 2022
Biotechnology🌐 excision.bio
Website LinkedIn
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
12
Total investors
2
Early stage
5
Mid stage
5
Late stage
2015
Founded

Investors

12 investors
All
Early stage
Mid stage
Late stage
Investor geography5 countries
United States
7
Singapore
2
Australia
1
Japan
1
Canada
1
Investor activity2016–2022 · investors recorded per year
201612017120192202032021320222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Excision BioTherapeutics?
Excision BioTherapeutics has 12 investors on record on gritt.io, including 2 early-stage backers, 5 mid-stage and 5 late-stage investors.
When did Excision BioTherapeutics last raise funding?
The most recent investment in Excision BioTherapeutics recorded on gritt.io was in 2022.
When was Excision BioTherapeutics founded?
Excision BioTherapeutics was founded in 2015.
What industry is Excision BioTherapeutics in?
Excision BioTherapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Excision BioTherapeutics based?
Excision BioTherapeutics is headquartered in Watertown, United States.